Prospective study to determine early hypertrophy of the contra-lateral liver lobe after unilobar, Yttrium-90, selective internal radiation therapy in patients with hepatocellular carcinoma
Author:
Funder
SingHealth Foundation
Sirtex Medical
Publisher
Elsevier BV
Subject
Surgery
Reference20 articles.
1. GLOBOCAN 2008, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10;The International Agency for Research on Cancer (IARC),2010
2. Global cancer statistics;Jemal;CA Cancer J Clin,2011
3. Importance of tumor size as a prognostic factor after partial liver resection for solitary hepatocellular carcinoma: implications on the current AJCC staging system;Goh;J Surg Oncol,2016
4. Comparison of hepatocellular carcinoma in Eastern versus Western populations;Choo;Cancer,2016
5. Remnant liver regeneration after two-stage hepatectomy for multiple bilobar colorectal metastases;Tanaka;Eur J Surg Oncol,2007
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Contralateral Hypertrophy Post Yttrium-90 Transarterial Radioembolization in Patients With Hepatocellular Carcinoma and Portal Vein Tumor Thrombus;Cureus;2024-04-29
2. Assessing regional hepatic function changes after hypertrophy induction by radioembolisation: comparison of gadoxetic acid-enhanced MRI and 99mTc-mebrofenin hepatobiliary scintigraphy;European Radiology Experimental;2024-01-29
3. Dose finding study for unilobar radioembolization using holmium-166 microspheres to improve resectability in patients with HCC: the RALLY protocol;BMC Cancer;2023-08-18
4. A prospective, multicenter, open-label, single-arm clinical trial design to evaluate the safety and efficacy of 90Y resin microspheres for the treatment of unresectable HCC: the DOORwaY90 (Duration Of Objective Response with arterial Ytrrium-90) study;BMC Gastroenterology;2022-03-28
5. Nuclear Medicine Therapy in primary liver cancers;Nuclear Medicine and Molecular Imaging;2022
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3